In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression. Big Health, the leading provider of non-drug digital treatments for mental health, has now acquired Limbix. In addition to health care providers, SparkRx will be made available to Big Health’s employer, public sector, health systems and health plan customers, and through the company’s strategic distribution agreements with pharmacy benefit managers (PBMs), significantly increasing nationwide access.
In this episode, we cover:
Origin of the company and story behind the name 'Limbix'
The funding journey and key milestones achieved
The choice to focus on the young adult population in particular
Patient experience with SparkRx
Defining good patient engagement in adolescent mental health
Evidence generation and FDA submission process
Business hypthothesis and scaling plan
The future of the PDT market
Guest Links and Resources:
Connect with Benjamin Alouf, MD on LinkedIn
Visit Limbix.com
Episode PDF
Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix
Host Links:
Eugene Borukhovich: Twitter | LinkedIn
Chandana Fitzgerald, MD: Twitter | LinkedIn
YourCoach.health: Website | Twitter
Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
